Acinetobacter infections: A growing threat for critically ill patients

Epidemiology and Infection

Volumn 136, Issue 8, 2008, Pages 1009-1019

  Falagas, M E ^a,b   Karveli, E A ^a   Siempos, I I ^a   Vardakas, K Z ^a  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASIAN; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CRITICALLY ILL PATIENT; EUROPEAN UNION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; RESPIRATORY TRACT INFECTION; REVIEW; SCANDINAVIA; UNITED STATES; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS;

EID: 47249114909     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807009478     Document Type: Review

References (74)

1. Alberti C, et al. Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Medicine 2002; 28: 108-121.
2. Trilla A. Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Medicine 1994; 20 (Suppl. 3): 1-4.
3. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clinical Infectious Diseases 2006; 42: 692-699.
4. Fagon JY, et al. Mortality attributable to nosocomial infections in the ICU. Infection Control and Hospital Epidemiology 1994; 15: 428-434.
5. Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: A systematic review of matched cohort and case-control studies. Critical Care 2006; 10: R48.
6. Warskow AL, Juni E. Nutritional requirements of Acinetobacter strains isolated from soil, water, and sewage. Journal of Bacteriology 1972; 112: 1014-1016.
7. Anstey NM, et al. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumonnii, with carriage in the throat in at-risk groups. Journal of Clinical Microbiology 2002; 40: 685-686.
8. Zapor MJ, Moran KA. Infectious diseases during wartime. Current Opinion in Infectious Diseases 2005; 18: 395-399.
9. Crowe M, et al. Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. European Journal of Clinical, Microbiology and Infectious Diseases 1998; 17: 377-384.
10. Bang RL, et al. Burn septicaemia: An analysis of 79 patients. Burns 1998; 24: 354-361.
11. Wisplinghoff H, et al. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 2004; 39: 309-317.
12. Costantini M, et al. Hospital acquired infections surveillance and control in intensive care services. Results of an incidence study. European Journal of Epidemiology 1987; 3: 347-355.
13. Jimenez P. et al. Incidence and etiology of pneumonia acquired during mechanical ventilation. Critical Care Medicine 1989; 17: 882-885.
14. Fussle R, et al. Microbiological care of ventilated intensive care patients. Feasibility of diagnosis and therapy of pulmonary infection. Anaesthetist 1991; 40: 491-496.
15. Garrouste-Orgeas M, et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. American Journal of Respiratory and Critical Care Medicine 1997; 156: 1647-1655.
16. Barsic B. et al. Antibiotic resistance among gram-negative nosocomial pathogens in the intensive care unit: Results of 6-year body-site monitoring. Clinical Therapeutics 1997; 19: 691-700.
17. Trouillet JL, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. American Journal of Respiratory and Critical Care Medicine 1998; 157: 531-539.
18. Garcia-Garmendia JL, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: A cohort study. Clinical Infectious Diseases 2001; 33 939-946.
19. Artigas AT, et al. Risk factors for nosocomial pneumonia in critically ill trauma patients. Critical Care Medicine 2001; 29 304-309.
20. Akca O, et al. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: Selected multiresistant versus nonresistant bacteria. Anesthesiology 2000; 93: 638-645.
21. Gruson D, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. American Journal of Respiratory and Critical Care Medicine 2000; 162: 837-843.
22. Cendrero JAC, et al. Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest 1999; 116: 462-470.
23. Heckmann JG, et al. Nosocomial pneumonias in a neurology intensive care unit. Deutsche Medizinische Wochenschrift 1999; 124: 919-924.
24. Weist K, et al. How many nosocormial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infection Control and Hospital Epidemiology 2002; 23: 127-132.
25. Vosylius S, Sipylaite J, Ivaskevicius J. Intensive care unit acquired infection: Prevalence and impact on morbidity and mortality. Acta Anaesthesiologica Scandinavica 2003; 47: 1132-1137.
26. Sofianou DC, et al. Analysis of risk factors for ventilator-associated pneumonia in a multidisciplinary intensive care unit. European Journal of Clinical Microbiology and Infectious Diseases 2000; 19: 460-463.a
27. Hanberger H, et al. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scandinavian Journal of Infectious Diseases 2004; 36: 24-30.
28. Ertugrul BM, et al. Ventilator-associated pneumonia in surgical emergency intensive care unit. Saudi Medical Journal 2006; 27: 52-57.
29. Piazza O, et al. Incidence of antimicrobial-resistant ventilator associated pneumonia: An eighteen-month survey. Panminerva Medizine 2005; 47: 265-267.
30. Richards MJ, et al. Nosocomial infections in medical intensive care units in the United States. Critical Care Medicine 1999; 27: 887-892.
31. Kollef MH, et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108: 1655-1662.
32. Wood GC, et al. Evaluation of a clinical pathway for ventilator-associated pneumonia: Changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. Surgical Infections 2005; 6: 203-213.
33. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clinical Infectious Diseases 2005; 41 848-854.
34. Santucci SG, et al. Infections in a burn intensive care unit: Experience of seven years. Journal of Hospital Infections 2003; 53: 6-13.
35. Bilevicius E, et al. Multiple organ failure in septic patients. Brazilian Journal of Infectious Diseases 2001; 5: 103-110.
36. Chung KI, et al. Nosocomial pneumonia in medico-surgical intensive care unit. Journal of Korean Medical Science 1992; 7 241-251.
37. Singh AK, et al. Antibiotic sensitivity pattern of the bacteria isolated from nosocomial infections in ICU. Journal of Communicable Diseases 2002; 34: 257-263.
38. Sun T, et al. Retrospective study on clinical features and risk factors of ventilator-associated pneumonia. Zhonghua Nei Ke Za Zhi 2002; 41: 468-471.
39. Mahmood A. Blood stream infections in a medical intensive care unit: Spectrum and antibiotic susceptibilicy pattern. Journal of Pakistan Medical Association 2001; 51: 213-215.
40. Wu CL, et al. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest 2002; 122: 662-668.
41. Rozaidi SW, Sukro J, Dan A. The incidence of nosocomial infection in the Intensive Care Unit, Hospital Universiti Kebangsaan Malaysia: ICU-acquired nosocomial infection surveillance program 1998-1999. Medical Journal of Malaysia 2001; 56: 207-222.
42. Hira HS, Zachariah S, Kumar R. Evaluation of ventilator-associated lower respiratory tract infection and tracheobronchial aspiration of gastrointestinal contents. Journal of the Association of Physicians of India 2002; 50: 1381-1385.
43. Erbay H, et al. Nosocomial infections in intensive care unit in a Turkish university hospital: A 2-year survey. Intensive Care Medicine 2003; 29: 1482-1488.
44. Kanafani ZA, et al. Ventilator-associated pneumonia at a tertiary-care center in a developing country: Incidence, microbiology, and susceptibility patterns of isolated microorganisms, Infection Control and Hospital Epidemiology 2003; 24: 864-869.
45. Pawar M, et al. Ventilator-associated pneumonia: Incidence, risk factors, outcome, and microbiology. Journal of Cardiothoracic and Vascular Anesthesia 2003; 17: 22-28.
46. Pawar M, et al. Central venous catheter-related blood stream infections: Incidence, risk factors, outcome, and associated pathogens. Journal of Cardiothoracic and Vascular Anesthesia 2004; 18: 304-308.
47. Namiduru M, et al. Antibiotic resistance of bacterial ventilator-associated pneumonia in surgical intensive care units. Journal of Internal Medicine Research 2004; 32: 78-83.
48. Agarwal R, et al. Epidemiology, risk factors and outcome of nosocomial infections in a Respiratory Intensive Care Unit in North India. Journal of Infection 2005; 53: 98-105.
49. Meric M, et al. Intensive care unit-acquired infections: incidence, risk factors and associated mortality in a Turkish university hospital. Japanese Journal of Infectious Diseases 2005; 58: 297-302.
50. Mulin B, et al. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. European Journal of Clinical Microbiology and Infectious Diseases 1995; 14: 569-576.
51. Hanberger H. et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. Journal of the American Medical Association 1999; 281: 67-71.
52. Siegrist HH, Nepa MC, Jacquet A. Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology/ oncology patients in Switzerland: A multicentre study. Journal of Antimicrobial Chemotherapy 1999; 43: 51-54.
53. Barsic B, et al. Antibiotic resistance among nosocomial isolates in a Croatian intensive care unit-results of a twelve-year focal surveillance of nosocomial infections. Journal of Chemotherapy 2004; 16: 273-281.
54. Krause R, et al. In vitro activity of newer broad spectrum beta-lactain antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Australian Carbapenem Susceptibility Surveillance Group. Wiener Klinische Wochenschrift 1999; 111: 549-554.
55. Villari P, et al. Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy. American Journal of Infection Control, 1999; 27 247-253.
56. Jones ME, et al. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002). Annals of Clinical Microbiology and Antimicrobials 2004; 3: 14-24.
57. Garnacho-Montero J. et al. Acinetobacter baumannii ventilator-associated pneumonia: Epidemiological and clinical findings. Intensive Care Medicine 2005; 31: 649-655.
58. Agodi A, et al. Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital. Clinical Microbiology and Infection 2006; 12: 241-247.
59. Wisplinghoff H, et al. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clinical Infectious Diseases 2000; 31: 690-697.
60. Friedland I, et al. Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000. Diagnostic Microbiology and Infectious Disease 2003; 45: 245-250.
61. Namias. N, et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. Journal of Trauma 2000; 49: 638-645.
62. Karlowsky JA, et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrobial Agents and Chemotherapy 2003; 47: 1681-1688.
63. Tognim MC, et al. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: Five-year report of the SENTRY Antimicrobial Surveillance Program. International Journal of Infectious Diseases 2004; 8: 284-291.
64. Gulati S, et al. Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU. Neurology India 2001; 49: 134-137.
65. Gunseren F, et al. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. Journal of Antimicrobial Chemotherapy 1999; 43: 373-378.
66. Jang TN, et al. Nosocomial gram-negative bacteremia in critically ill patients: Epidemiologic characteristics and prognostic factors in 147 episodes. Journal of the Formosan Medical Association 1999; 98: 465-473.
67. Yucesoy M, et al. Antimicrobial resistance of gram-negative isolates from intensive care units in Turkey: Comparison to previous three years. Journal of Chemotherapy 2000; 12: 294-298.
68. Wang H, Chen M. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagnostic Microbiology and Infectious Disease 2005, 51: 201-208.
69. Hsueli PR, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microbial Drug Resistance 2001; 7: 373-382.
70. Thongpiyapoom S, et al. Device-associated infections and patterns of antimicrobial resistance in a medical-surgical intensive care-unit in a university hospital in Thailand. Journal of the Medical Association of Thailand 2004; 87: 819-824.
71. Yildirim S, et al. Bacteriological profile and antibiotic resistance: Comparison of findings in a burn intensive care unit, other intensive care units, and the hospital services unit of a single center. Journal of Burn Care and Rehabilitation 2005; 26: 488-492.
72. Akcam FZ, et al. Microbiological surveillance in the intensive care unit: A tertiary hospital experience. Medical Science Monitor 2006; 12: CR81-85.
73. Potgieter PD, et al. Nosocomial infections in a respiratory intensive care unit. Critical Care Medicine 1987; 15: 495-498.
74. Hammond JM, Potgieter PD. Long-term effects of selective decontamination on antimicrobial resistance, Critical Care Medicine 1995; 23: 637-645.